Understanding factors affecting treatment outcomes in lumbar spine osteoarthritis
Official title: Prognostic Factors of Efficacy in Corticoid and Anesthetic Joint Infiltration for the Treatment of Patients With Low Back Pain Secondary to Zygapophyseal Osteoarthritis: a Prospective Cohort Study
Run by Hospital Israelita Albert Einstein · NCT03304730 · Data updated 2026-11-12
This study is trying to see how different factors, like MRI results and patient history, can affect how well treatment works for people with low back pain caused by arthritis in the spine.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 147 (estimated) |
| Sponsor | Hospital Israelita Albert Einstein Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (São Paulo, São Paulo) |
| Status | Recruiting |
| Started | September 1, 2017 |
| Main results expected | December 2028 |
| Study ends | December 2029 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT03304730 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with persistent low back pain for at least three months, particularly those who have not responded to traditional treatments.
✕Probably not a fit
Patients with symptomatic lumbar spinal stenosis or those under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the prognostic factors associated with treatment outcomes for patients suffering from degenerative arthropathy of the lumbar spinal facet joint. It focuses on the relationship between magnetic resonance imaging findings of facet osteoarthritis and patient characteristics to predict clinical outcomes following facet infiltration treatment. The study aims to enhance diagnostic accuracy and treatment effectiveness for low back pain, a prevalent health issue affecting a significant portion of the population. Participants will be assessed based on their pain characteristics and treatment history to identify factors that may influence their recovery.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with low back pain due to facet osteoarthritis.
How similar studies have gone: While similar studies have explored treatment outcomes for low back pain, this specific approach focusing on prognostic factors in facet osteoarthritis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria The following are inclusion criteria for participants: * Older than 18 years; * Fluent or native Portuguese language speaker; * Continuous or intermittent low back pain for at least three months; * Low back pain with or without irradiation to the gluteal region indicating facet syndrome (pain is aggravated by spine extension or bending toward the affected side; pain is exacerbated by prolonged sitting or walking up steps, as well as retaining one position for a prolonged time); * Failure of traditional treatment includes, but is not limited to, physical or drug therapy; * Understand the purpose of the study; * Voluntarily provide a free and informed consent form, by themselves or through their partners, and complete the questionnaires, before undergoing infiltration, over the telephone or online during the follow-up. Exclusion criteria The following are exclusion criteria for participants: * Younger than 18 years old, * Symptomatic lumbar spinal stenosis with claudication or radiculopathy; * Evidence of radiculopathy; * Active rheumatologic diseases; * Congenital or acquired deformities of the lumbar spine; * Fracture or sequel of lumbar spine fracture of traumatic, pathological or osteoporotic origin; * Surgical manipulation of the lumbar spine; * MRI scans of limited quality and incomplete sequences; * Treated with systemic steroids less than one month before the IFI; * Treated with IFI with steroids within the last six months; * Diagnosed with uncontrolled diabetes mellitus; * History of allergy to anesthetics or adverse reaction to steroids; * Pregnant women or women who breastfed; * Who could not be contacted over the phone during follow-up.
Where it's running
-
Hospital Israelista Albert Einstein
São Paulo, São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Joao C Rodrigues, MD — Hospital Israelita Albert Einstein
- Study coordinator: Joao C Rodrigues, MD
- Email: joao.rodrigues@einstein.br
- Phone: 551121512452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cosmetics to Improve Self-Esteem and Quality of Life for Black Women with Facial Hyperpigmentation
This study tests a skincare routine containing bioceramides and niacinamide to see if it can lessen facial PIH and boost self-esteem and quality of life in Black Brazilian women.
-
Long-term Outcomes After ICU Treatment for Sepsis
This study follows adults who were treated in ICUs for sepsis to see how they do during hospital stay and up to a year after discharge.
-
Gastric contents after fasting in people taking tirzepatide
This project will use bedside ultrasound to see if adults taking tirzepatide, compared with people not on the drug, still have stomach contents after standard fasting.
-
Using hydrogen peroxide and ultraviolet-C light to disinfect ICU surfaces
This trial will test whether adding hydrogen peroxide aerosol or automated UV-C light to routine cleaning lowers infection rates in adults admitted to participating intensive care units.
-
Tracking acute treatment and long-term outcomes in children with meningitis
This registry will collect care and outcome information to see how current treatments affect short- and long-term outcomes in children under 18 with suspected meningitis in Brazil.
-
Acute treatment and long-term follow-up of adults with infectious meningitis
This project will collect information to see how adults hospitalized with different types of infectious meningitis are treated and how they do during and after hospitalization in Brazil.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.